コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ological measurements with new insights from omics.
2 ics related to next-generation breast cancer omics.
3 , we present Online Resource for Integrative Omics, a web-based resource with an intuitive user inter
4 a "verified" dataset based on cross-strategy/omics agreement was defined following their comparison w
5 Herein, we discuss both human data from meta'omics analyses and data from mechanistic studies in cell
10 from remote sensors, physiological and multi-omics analyses to assess the feasibility of detecting ti
11 g adenocarcinomas (LuADCs) using integrative omics analyses, and discover that mRNA levels of DTL, DC
16 ances have been made using carbon isotopes, 'omics' analyses and surveys of respiration rates in meso
18 athophysiology, we performed multi-platform 'omics analysis of peripheral blood mononuclear cells and
20 of Cell, insights from a longitudinal multi-omics analysis of the largest yet-reported cohort of mel
21 S/MS), a widely used method for comparative 'omics analysis, experiences challenges with compound ide
22 nd validation; biomarker discovery and multi-omics analysis, to explore somatic mutations and cancer
25 findings highlight the power of integrative omics and biochemical analyses for annotating the functi
26 studies building on the explosive growth in omics and cell biology methods have facilitated the in-d
29 e a Precancer Atlas (PCA), integrating multi-omics and immunity - basic tenets of the neoplastic proc
30 and models in developing an integrated multi-omics and immunity PCA - an immense national resource to
32 ularly with respect to the incorporation of -omics and next-generation sequencing data and continual
33 We discuss key differences between MS-based -omics and other booming -omics technologies and highligh
34 The subject matter experts invited to the Omics and Precision Oncology Workgroup were tasked with
35 CO convened two complementary workshops: the Omics and Precision Oncology Workshop in October 2016 an
36 following areas of need were identified: 1) omics and precision oncology, 2) advancing interoperabil
37 ide association studies in humans and mice, -omics and systems genetics approaches, and unique experi
38 accompanied by the growing availability of "-omics" and ancient DNA data, promises a new era in our u
39 hnological innovations, such as single cell "omics" and human stem cell derivation, have now greatly
41 to microfluidics for mammalian single-cell 'omics' and discuss challenges and future opportunities.
42 dual omics data itself as well as from other omics, and 2) simultaneously impute multiple missing omi
43 emporary technologies in molecular biology, -omics, and cell biology aids in exploring the comparativ
44 rom diverse disciplines (e.g., biochemistry, omics, and computational biology; microbiology, immunolo
45 for the potential of scanning LC-FAIMS-MS in omics applications is demonstrated for the nontargeted p
47 functions against HIV using a novel focused omics approach ("communicome") has the potential to sign
48 In this work, we used an Integrative FourD omics approach (INFO) that consists of collecting and an
49 t accompany lung adenocarcinomas, we took an omics approach in profiling both the coding genes and th
50 dy underlines the potential role of an inter-omics approach in understanding the metabolic pathways i
57 g multiple genetic backgrounds, and multiple omics approaches (transcriptomics, proteomics and high t
58 on on microplastics at sea using imaging and omics approaches are further indicated to better underst
59 mixture of microbial species) and other meta-omics approaches hold even greater promise for providing
60 ions, but few studies have used non-targeted omics approaches to explore differences between diving m
63 new regulators in IRF5 pathway, we used two "omics" approaches: affinity purification coupled with ma
65 publicly available datasets and performed "-omics"-based integrative, and network topology analyses
66 iations and the promise of high-throughput "-omics"-based systems biology approach in providing great
68 efit from, current and future application of omics-based approaches to understand the host response i
71 igated using gingival tissue samples through omics-based whole-genome transcriptomics while using hea
75 This work provides an example of how meta-omics can increase our understanding of industrial waste
77 is expansive, high-resolution atlas of multi-omics changes yields insights into cell-type-specific co
79 mics, a consistent, quality-controlled multi-omics compendium for Escherichia coli with cohesive meta
83 he ever more readily available and abundant -omics data (i.e. transcriptomics, proteomics and metabol
84 STATION database integrates diverse types of omics data across mammals to advance understanding of th
85 io of statistical tools for high-dimensional omics data analysis covering normalization, pattern reco
87 g the gap between the complexity captured by omics data and governing principles of proteome allocati
88 systematically integrate multi-dimensional -omics data and reconstruct the gene regulatory networks.
90 knowledgebase that integrates ecosystem-wide omics data and the development of molecular tools/resour
93 od with five imputation methods using single omics data at different noise levels, sample sizes and d
94 nt metabolic system and also illustrates how omics data can be integrated to generate new hypotheses
95 organoids and 59 xenografts, with extensive omics data comparing donor tumours and derived models pr
96 study presents an integrative procedure for -omics data exploitation, giving rise to biologically rel
98 Forest regression for integrating multiple ~ omics data for prediction of four quality traits of pota
99 ernal metabolic fluxes and leveraging other -omics data for the scientific study of cellular metaboli
101 epresent a general formalism for integrating omics data from any experimental condition into constrai
102 variant, and that models trained on matched -omics data from non-cancerous cell-lines are able to pre
103 as become the method of choice for analyzing omics data in general and gene expression data in partic
106 IP-Array 2, to integrate additional types of omics data including long-range chromatin interaction, o
108 tions for application of metabolomics-based -omics data integration in understanding disease pathogen
112 nvironmental ontology reconstructed from the omics data is substantially different and complementary
114 e estimates of missing value from individual omics data itself as well as from other omics, and 2) si
115 ion designs, (c) integration of multi-layer -omics data leading to identification of genes and pathwa
117 st decade, as large amounts of experimental 'omics data relevant to glycosylation processing have acc
120 we show that pairwise integration of primary omics data reveals regularities that tie cellular proces
122 cellular fractionation proteomics with other omics data sets and is generally applicable to other tis
123 states with high collagen, is now utilizing 'omics data sets and is revealing polymer physics-type, n
126 we present an approach to integrate these ~ omics data sets for the purpose of predicting phenotypic
127 Modern time series gene expression and other omics data sets have enabled unprecedented resolution of
129 glycomics measurements together with other 'omics data sets will lead to a deeper understanding and
130 We conclude that this ontology can, from omics data sets, enable the development of detailed SCP
134 s the heterogeneity present in the different omics data sources, which makes it difficult to discern
136 n package GSAR are applicable to any type of omics data that can be represented in a matrix format.
139 able strategy to integrate multiple lines of omics data to identify a core pool of regulator targets.
140 lementary information encoded in each of the omics data to identify novel driver genes through an int
142 egy for selecting and integrating multiple ~ omics data using random forest method and selected repre
143 utation methods mainly focus on using single omics data while ignoring biological interconnections an
145 ell- and condition-specific high-dimensional Omics data with interaction information from existing da
149 Integrative analysis of high-throughput omics data with virologic and histopathologic data uncov
150 approach for the analysis of IgAN-relevant -omics data, aiming at identification of novel molecular
151 Given the abundance of genome sequencing and omics data, an opprtunity and challenge in bioinformatic
153 reasing availability of multiple additional -omics data, this quest has been frustrated by various th
154 gies allow for measurements of many types of omics data, yet the meaningful integration of several di
155 able at that time nor the scarcely available omics data-let alone metabolic modeling and other nowada
171 l interrogation of high-dimensional complex "omics" data in an interactive and easily interpretable w
172 lly expressed genes (DEGs) across different 'omics' data types or multi-dimensional data including ti
173 identifying regulatory relationships across 'omics' data within an organism and for comparative gene
174 must accommodate the challenges inherent in 'omics' data, including high-dimensionality, noise, and t
175 sholds with applications for high throughput omics-data, optimal alpha, which minimizes the probabili
177 ve analysis appears a safer way to evaluate -omics datasets and ultimately generate models from valid
179 as proposed to integrate multiple correlated omics datasets for improving the imputation accuracy.
180 m that facilitates the easy interrogation of omics datasets holistically to improve 'findability' of
182 is trackRank, a novel algorithm for ranking omics datasets that fully uses the numerical content of
184 omputational pipelines for integrating multi-omics datasets, and functional perturbation to systemica
185 markers from four different high-throughput omics datasets, namely epigenomics, transcriptomics, gly
190 er - NASFinder) to identify tissue-specific, omics-determined sub-networks and the connections with t
191 ies have led to an increase of datasets from omics disciplines allowing the understanding of the comp
193 is work provides an integrative framework of omics-driven predictive modelling that is broadly applic
194 ate the implementation of a HC approach for "omics-driven" classification of 15 bacterial species at
200 high-throughput DNA sequencing technologies, omics experiments have become the mainstay for studying
202 ematical biology; functional and comparative OMICs; gene editing; expanded use of model organisms; an
204 genomics appearing as part of the series on "omics." Genomics pertains to all components of an organi
208 ative analysis of clinically-annotated multi-omics HNSCC data released by the Cancer Genome Atlas.
210 s Europe were combined with systems biology (omics, IgE measurement using microarrays) and environmen
213 ddresses the necessity to integrate multiple omics information arising from dynamic profiling in a pe
221 ain a multi-scale model that integrates four omics layers to predict genome-wide concentrations and g
224 order, when iterating through the different "omics" layers, and implementing this algorithm in the fa
226 tact and degraded cartilage in at least two -omics levels, 16 of which have not previously been impli
227 y differentially regulated across all three -omics levels, confirming their differential expression i
228 rioritize biomarkers, to integrate different omics levels, to design follow-up functional assay exper
229 s to assess conditional dependencies between omics markers and phenotypes while eliminating mediated
230 rious components of the epigenome into multi-omics measurements allows for studying cellular heteroge
234 red to studies of a single omics type, multi-omics offers the opportunity to understand the flow of i
236 ome of acute hyperoxic lung injury using the omics platforms: microarray and Reverse Phase Proteomic
237 the integration of metabolomics with other "omics" platforms will allow us to gain insight into path
240 ional data sets generated from recent cancer omics profiling projects have presented new challenges a
241 including annotated genomes, high-throughput omics profiling, and genome editing, have begun to eluci
245 By integrating bioinformatics approaches, omics resources and transcriptome collections today avai
246 ructure has grown rapidly, simulations on an omics scale are not yet widespread, primarily because so
250 the current published data regarding other "omics" strategies-proteomics, metabolomics, and the micr
252 ion of metabolic pathways - a common goal of omics studies - could be incorrect if well-recognized pa
255 data from RNA, protein, and metabolite-based omics studies is discussed, along with new models and ne
256 UVR) on skin homeostasis, we performed multi-omics studies to characterize UV-induced genetic and epi
261 heart failure, we performed the first multi-omics study in myocardial tissue and blood of patients w
265 omatin immunoprecipitation (ChIP-seq) is the omics technique that enables genome wide localization of
267 a direction for the integration of multiple omics techniques in future nutrigenomic studies aimed at
270 atics platform to stay current with emerging omics technologies and analysis methods to continue supp
272 this review, we provide an overview of such omics technologies and focus on methods for their integr
273 s between MS-based -omics and other booming -omics technologies and highlight what we view as the fut
275 Though barley genome sequence and advanced omics technologies are available, till date none of the
276 We conclude with a perspective on new multi-omics technologies capable of integrating several readou
280 ntly descriptive nature of localization and -omics technologies to provide functional, quantitative,
281 a multitude of advantages as demonstrated by omics technologies, helping to support both government a
284 nt of many innovative tools derived from the omics technologies, transplant medicine is slowly enteri
288 logy" centered on cutting-edge genetic and "-omics technologies." Framingham Heart Study investigator
289 been a driving force in recent years in the "omics" technologies and while great strides have been ac
290 cal imaging, electronic health records, and "omics" technologies have produced a deluge of data.
292 Cardiac Failure, Cardiomyopathies, Genetics, Omics, & Tissue Regeneration, and Hypertension (1-60).
294 y highlights the strength of using different omics to identify novel biomarkers of drug response and
296 s of relatively small sets of interrelated ~ omics variables that can predict, with higher accuracy,
299 In this context, metagenomics and functional omics will likely play a central role as they will allow
300 increasingly implemented in high throughput omics workflows, and new informatics approaches are nece
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。